This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Marso, S. P Search for Related Content Social Bookmarking                         What's this?

Review: The pathogenesis of type 2 diabetes and cardiovascular disease

The Mid America Heart Institute, Saint Lukes Hospital, 4401 Wornall, Kansas City, Missouri 64111, USA, smarso{at}saint-lukes.org

Type 2 diabetes mellitus is increasing in prevalence, and is a potent risk factor for the development of atherosclerotic vascular disease and increased risk of adverse cardiovascular events. Approximately 15—25% of patients presenting with ischaemic heart disease have a history of diabetes mellitus. This cohort of patients continues to be at heightened short and long-term risk. This review highlights the many proposed biological drivers that likely play a deterministic role in the cardiovascular outcome of patients with type 2 diabetes mellitus.

Key Words: coronary artery disease • thrombosis • type 2 diabetes mellitus • myocardial infarction • atherosclerosis.

References

• Ford ES, Giles WH, Dietz WH Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002;287:356-9.[Abstract/Free Full Text]
• Wingard DL, Barrett-Connor E. Heart Disease and Diabetes. Diabetes in America. Washington, DC. US Department of Health and Human Services. NIH Publication No. 95-1468. U.S. Gov't. Printing Office: 1996-410-653. 2nd Ed. 1995:429-58.
• Fagot-Campagna A. Emergence of type 2 diabetes mellitus in children: epidemiological evidence. J Pediatr Endocrinol Metab 2000;13(suppl 6):1395-402.[Web of Science]
• Harris MI Diabetes in America: epidemiology and scope of the problem. Diabetes Care 1998;21(suppl 3):C11-4.[Web of Science][Medline] [Order article via Infotrieve]
• McKinlay J., Marceau L. US public health and the 21st century: diabetes mellitus. Lancet 2000;356:757-61.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Gu K., Cowie CC, Harris MI Diabetes and decline in heart disease mortality in US adults (see comments). JAMA 1999;281:1291-7.[Abstract/Free Full Text]
• Abizaid A., Costa MA, Centemero M. et al. Clinical and economic impact of diabetes mellitus on percutaneous and surgical treatment of multivessel coronary disease patients: Insights from the Arterial Revascularization Therapy Study (ARTS) Trial. Circulation 2001;104:533-8.[Abstract/Free Full Text]
• Marso SP, Ellis SG, Gurm HS, Lytle BW, Topol EJ Proteinuria is a key determinant of death in patients with diabetes after isolated coronary artery bypass grafting. Am Heart J 2000;139:939-44.[Web of Science][Medline] [Order article via Infotrieve]
• Marso SP, Ellis SG, Tuzcu M. et al. The importance of proteinuria as a determinant of mortality following percutaneous coronary revascularization in diabetics. J Am Coll Cardiol 1999;33:1269-77.[Abstract/Free Full Text]
• Kip KE, Faxon DP, Detre KM, Yeh W., Kelsey SF, Currier JW Coronary angioplasty in diabetic patients. The National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry (see comments). Circulation 1996;94:1818-25.[Abstract/Free Full Text]
• Roffi M., Chew DP, Mukherjee D. et al. Platelet glycoprotein IIb/IIIa inhibitors reduce mortality in diabetic patients with non-ST-segment-elevation acute coronary syndromes. Circulation 2001;104:2767-71.[Abstract/Free Full Text]
• Stone GW, Moliterno DJ, Bertrand M. et al. Impact of clinical syndrome acuity on the differential response to 2 glycoprotein IIb/IIIa inhibitors in patients undergoing coronary stenting: the TARGET Trial. Circulation 2002;105:2347-54.[Abstract/Free Full Text]
• Williams SB, Cusco JA, Roddy MA, Johnstone MT, Creager MA Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus. J Am Coll Cardiol 1996;27:567-74.[Abstract]
• McVeigh GE, Brennan GM, Johnston GD et al. Impaired endothelium-dependent and independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1992;35:771-6.[Web of Science][Medline] [Order article via Infotrieve]
• Morris SJ, Shore AC, Tooke JE Responses of the skin microcirculation to acetylcholine and sodium nitroprusside in patients with NIDDM. Diabetologia 1995;38:1337-44.[Web of Science][Medline] [Order article via Infotrieve]
• Lim SC, Caballero AE, Smakowski P., LoGerfo FW, Horton ES, Veves A. Soluble intercellular adhesion molecule, vascular cell adhesion molecule, and impaired microvascular reactivity are early markers of vasculopathy in type 2 diabetic individuals without microalbuminuria. Diabetes Care 1999;22:1865-70.[Abstract/Free Full Text]
• Saito Y., Nakao K., Mukoyama M., Imura H. Increased plasma endothelin level in patients with essential hypertension. N Engl J Med 1990;322:205.[Web of Science][Medline] [Order article via Infotrieve]
• Pilote L., Miller DP, Califf RM, Rao JS, Weaver WD, Topol EJ Determinants of the use of coronary angiography and revascularization after thrombolysis for acute myocardial infarction [see comments]. N Engl J Med 1996;335:1198-205.[Abstract/Free Full Text]
• Naruse K., King G. Effect of Diabetes on Endothelial Function. In: Johnstone M, Veves A, eds. Diabetes and Cardiovascular Disease. Totowa: Humana Press Inc., 2001:45-64.
• Inoguchi T., Battan R., Handler E., Sportsman JR, Heath W., King GL Preferential elevation of protein kinase C isoform beta II and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation. Proc Natl Acad Sci USA 1992;89:11059-63.[Abstract/Free Full Text]
• Ishii H., Jirousek MR, Koya D. et al. Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor. Science 1996;272:728-31.[Abstract]
• Arcaro G., Zenere BM, Saggiani F. et al. ACE inhibitors improve endothelial function in type 1 diabetic patients with normal arterial pressure and microalbuminuria. Diabetes Care 1999;22:1536-42.[Abstract/Free Full Text]
• O'Driscoll G., Green D., Maiorana A., Stanton K., Colreavy F., Taylor R. Improvement in endothelial function by angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. J Am Coll Cardiol 1999;33:1506-11.[Abstract/Free Full Text]
• Tomai F., Crea F., Gaspardone A. et al. Unstable angina and elevated c-reactive protein levels predict enhanced vasoreactivity of the culprit lesion. Circulation 2001;104:1471-6.[Abstract/Free Full Text]
• Pradhan AD, Manson JE, Rifai N., Buring JE, Ridker PM C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001;286:327-34.[Abstract/Free Full Text]
• Festa A., D'Agostino R., Jr., Howard G., Mykkanen L., Tracy RP, Haffner SM Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2000;102:42-7.[Abstract/Free Full Text]
• Fichtlscherer S., Rosenberger G., Walter DH, Breuer S., Dimmeler S., Zeiher AM Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease. Circulation 2000;102:1000-6.[Abstract/Free Full Text]
• Ziccardi P., Nappo F., Giugliano G. et al. Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation 2002;105:804-09.[Abstract/Free Full Text]
• Tschoepe D., Roesen P., Kaufmann L. et al. Evidence for abnormal platelet glycoprotein expression in diabetes mellitus. Eur J Clin Invest 1990;20: 166-70.[Web of Science][Medline] [Order article via Infotrieve]
• Aronson D., Bloomgarden Z., Rayfield E.j. Potential mechanisms promoting restenosis in diabetic patients. (Review) (103 refs). J Am Coll Cardiol 1996;27:528-35.[Abstract]
• Knobler H., Savion N., Shenkman B., Kotev-Emeth S., Varon D. Shear-induced platelet adhesion and aggregation on subendothelium are increased in diabetic patients. Thromb Res 1998;90:181-90.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Davi G., Ciabattoni G., Consoli A. et al. In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. Circulation 1999;99:224-9.[Abstract/Free Full Text]
• Shechter M., Merz CN, Paul-Labrador MJ, Kaul S. Blood glucose and platelet-dependent thrombosis in patients with coronary artery disease. J Am Coll Cardiol 2000;35:300-07.[Abstract/Free Full Text]
• Collaborative overview of randomised trials of antiplatelet therapy-I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration. BMJ 1994;308:81-106.[Abstract/Free Full Text]
• Physician's health study: aspirin and primary prevention of coronary heart disease. N Engl J Med 1989;321:1825-8.[Web of Science][Medline] [Order article via Infotrieve]
• Aspirin effects on mortality and morbidity in patients with diabetes mellitus. Early Treatment Diabetic Retinopathy Study report 14. ETDRS Investigators. JAMA 1992;268:1292-300.[Abstract/Free Full Text]
• Bhatt DL, Marso SP, Hirsch AT, Ringleb P., Hacke W., Topol EJ Superiority of clopidogrel versus aspirin in patients with a history of diabetes mellitus. J Am Coll Cardiol 2000;35:409A.
• Marso SP, Lincoff AM, Ellis SG et al. Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus: results of the EPISTENT (Evaluation of platelet IIb/IIIa inhibitor for stenting trial) diabetic substudy (see comments). Circulation 1999;100:2477-84.[Abstract/Free Full Text]
• Bhatt DL, Marso SP, Lincoff AM, Wolski KE, Ellis SG, Topol EJ Abciximab reduces mortality in diabetics following percutaneous coronary intervention. J Am Coll Cardiol 2000;35:922-8.[Abstract/Free Full Text]
• Holmes DR, Jr, Vlietstra RE, Smith HC et al. Restenosis after percutaneous transluminal coronary angioplasty (PTCA): a report from the PTCA Registry of the National Heart, Lung, and Blood Institute. Am J Cardiol 1984;53:77C-81C.[CrossRef][Medline] [Order article via Infotrieve]
• McClain DA, Paterson AJ, Roos MD, Wei X., Kudlow JE Glucose and glucosamine regulate growth factor gene expression in vascular smooth muscle cells. Proc Natl Acad Sci USA 1992;89:8150-4.[Abstract/Free Full Text]
• Roy S., Sala R., Cagliero E., Lorenzi M. Overexpression of fibronectin induced by diabetes or high glucose: phenomenon with a memory. Proc Natl Acad Sci USA 1990;87:404-08.[Abstract/Free Full Text]
• Unger E., Pettersson I., Eriksson UJ, Lindahl U., Kjellen L. Decreased activity of the heparan sulfate-modifying enzyme glucosaminyl N-deacetylase in hepatocytes from streptozotocin-diabetic rats. J Biol Chem 1991;266: 8671-4.[Abstract/Free Full Text]
• Zhou ZM, Marso SP, Schmidt AM et al. Blockade of Receptor for Advanced Glycation End-Products (RAGE) Suppresses Neointimal Formation in Diabetic Rat Carotid Artery Injury Model. Circulation 2000;102:II-246.
• Bornfeldt KE, Raines EW, Nakano T., Graves LM, Krebs EG, Ross R. Insulin-like growth factor-I and platelet-derived growth factor-BB induce directed migration of human arterial smooth muscle cells via signaling pathways that are distinct from those of proliferation. J Clin Invest 1994;93:1266-74.[Web of Science][Medline] [Order article via Infotrieve]
• Nishimoto Y., Miyazaki Y., Toki Y. et al. Enhanced secretion of insulin plays a role in the development of atherosclerosis and restenosis of coronary arteries: elective percutaneous transluminal coronary angioplasty in patients with effort angina. J Am Coll Cardiol 1998;32:1624-9.[Abstract/Free Full Text]
• Glagov S., Weisenberg E., Zarins CK, Stankunavicius R., Kolettis GJ Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 1987;316:1371-5.[Abstract]
• Kornowski R., Mintz GS, Lansky AJ et al. Paradoxic decreases in atherosclerotic plaque mass in insulin-treated diabetic patients. Am J Cardiol 1998;81:1298-304.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Van Belle E., Abolmaali K., Bauters C., McFadden EP, Lablanche JM, Bertrand ME Restenosis, late vessel occlusion and left ventricular function six months after balloon angioplasty in diabetic patients. J Am Coll Cardiol 1999;34:476-85.[Abstract/Free Full Text]
• Abaci A., Oguzhan A., Kahraman S. et al. Effect of diabetes mellitus on formation of coronary collateral vessels. Circulation 1999;99:2239-42.[Abstract/Free Full Text]
• Vinik AI, Erbas T., Park TS, Nolan R., Pittenger GL Platelet dysfunction in type 2 diabetes. Diabetes Care 2001;24:1476-85.[Abstract/Free Full Text]

The British Journal of Diabetes & Vascular Disease, Vol. 2, No. 5, 350-356 (2002)
DOI: 10.1177/14746514020020050201


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Marso, S. P Search for Related Content Social Bookmarking                         What's this?